Engineered IL-2 Fc fusion proteins
The present invention provides IL-2-Fc fusion proteins comprising IL-2 variants.
1. A polypeptide composition comprising a variant human IL-2 protein, wherein said variant human IL-2 protein comprises amino acid substitution(s) as compared to SEQ ID NO:2 selected from the group of T3A/D20N/T37R and T3A/D20N/N71K.
2. The polypeptide composition according to claim 1 , wherein said variant human IL-2 protein further comprises a C125S variant.
3. The polypeptide composition according to claim 1 , wherein said variant human IL-2 protein further comprises a C125A variant.
4. The polypeptide composition according to claim 1 , wherein said polypeptide composition is a heterodimeric protein complex comprising two protein monomers, wherein each protein monomer comprises said variant human IL-2 protein covalently attached to an Fc domain.
5. The polypeptide composition according to claim 4 , wherein said polypeptide composition is selected from the group consisting of XENP27564 (SEQ ID NOs:297 and 298), XENP27563 (SEQ ID NOs:295 and 296), XENP26105 (SEQ ID NOs:245 and 246), and XENP26109 (SEQ ID NOs:249 and 250).